Personalized Health Technologies and Translational Research Conference 2018

A conference on personalized health tools & technologies, for the community providing services to biomedical and translational researchers, and about the translational research for health care in and around Switzerland

When? June 18 to 21, 2018

Where? ETH Zurich, Switzerland

Overview

The next steps in personalized health. This conference brings together experts from multiple disciplines to explore present and future directions in the field of personalized health technologies and translational research. The goal is to tackle challenges in chemical hit identification, lead development, molecular circuit analyses, clinical bioinformatics, and multivariate statistics, as well as their application in innovative clinical personalized health approaches in oncology, immunology, infectious diseases, neurology, and cardiology.

From patient samples to molecular read outs. Progress in the laboratory representation of clinical material has enabled novel possibilities for discovery and diagnostics with thus far unrivaled proximity to the patient. Advanced cell systems such as organoids allow for in-depth molecular profiling and functional studies as well as investigation of responses to chemical and therapeutic agents. Combined with high-throughput screening and chemical biology, empirical projects of very large scope have not only become conceivable but also present themselves with feasible turnaround time.

Integration of molecular modalities and global knowledge. The continuous development of next-generation sequencing and mass spectrometry measurements allow for high-resolution characterization of biomolecules derived from patient samples or mouse models of disease. While early challenges of storage and compute capacity have largely been addressed, present ones are the integration and combined analysis of multifaceted data, including public online resources.

The future of translation — together. Research and development for personalized health show the greatest promise when all stakeholders collaborate closely. This includes the academic and clinical institutions, core facilities and medical labs, as well as hospitals and ultimately the patients.

Confirmed Speakers

Calvin Kuo (Standford University)
Professor of Medicine (Hematology)
Professor of Chemical and Systems Biology
Co-Lead, Cancer Biology Program, Stanford Cancer Center
Vice Chair for Basic and Translational Research, Department of Medicine
Olivier Elemento (Weill Cornell Medicine)
Director, Englander Institute for Precision Medicine
Associate Director, Institute for Computational Biomedicine
Co-Assistant Dean for Scientific Computing
Co-Director, WorldQuant Initiative for Quantitative Prediction
Co-Leader, Genetics, Epigenetics and Systems Biology Program, Meyer Cancer Center
Tewis Bouwmeester (Novartis)
Senior Unit Head, Department of Developmental and Molecular Pathways
Novartis Institutes for Biomedical Research (NIBR)
Nikolaus Schultz (Memorial Sloan Kettering Cancer Center)
Head of Knowledge Systems
Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Mikael Pittet (Massachusetts General Hospital)
Head of Pittet Laboratory of the Center for Systems Biology
Zlatko Trajanoski (Medical University of Innsbruck)
Director of Division of Bioinformatics, Biocenter
Carl H. June (University of Pennsylvania Perelman School of Medicine)
Richard W. Vague Professor in Immunotherapy
Director, Center for Cellular Immunotherapies
Director, Parker Institute for Cancer Immunotherapy

Audience

This conference brings together multidisciplinary experts to explore present and future challenges in the field of personalized health technologies and translational research.

We look forward to welcoming researchers, clinicians and scientists from university, industry and the public sector who are interested in the latest progress of personalized health technologies, translational research and development. Taking place six months after the first projects of the Swiss Personalized Health Network (SPHN) initiative have launched, the conference will give participants an opportunity to present first results and is thus very timely.

Agenda

The conference will be structured in nine sessions. The first four sessions (June 18-19) are organized by NEXUS Personalized Health Technologies with a focus on tools & technologies and the last 5 sessions (June 20-21) by the Competence Center Personalized Medicine (CC-PM) with a focus on translation & research:

Monday 18 June 2018
Tuesday 19 June 2018
08:30 - 09:00
Arrival & Registration

09:00 - 09:15
Welcome Address
08:30 - 09:15
Arrival & Registration

09:15 - 12:15
Session 1 - Advanced Cell Systems
09:15 - 12:15
Session 3 - Novel Therapeutics
12:05 - 13:30
Lunch & Poster Session
12:05 - 13:30
Lunch & Poster Session
13:45 - 16:15
Session 2 - Variant Interpretation
13:45 - 16:15
Session 4 - Integration of Clinical Data
16:45 - 18:30
Apéro & Poster Session
18:00
Conference Dinner


Wednesday 20 June 2018
Thursday 21 June 2018
08:30 - 09:00
Arrival & Registration
08:30 - 09:00
Arrival & Registration
09:00 - 11:35
Session 5 - Infectiology
09:00 - 11:35
Session 8 – Neurology
Coffee Break

Coffee Break

11:35 - 12:05
Session 6 – Immunology
11:35 - 12:05
Session 9 – Cardiology
12:05 - 13:30
Lunch & Poster Session
12:05 - 13:30
Lunch & Poster Session
13:30 - 15:05
Session 6 – continued
13:30 - 15:05
Session 9 – continued
15:30 - 17:35
Session 7 – Oncology
15:05 - 15:20
Summary & Farewell Coffee
17:35 - 19:00
Apéro & Poster Session

Organizers

NEXUS Personalized Health Technologies: an ETH Technology Platform created to enable and accelerate the execution of translational research projects by providing key technological resources, tools and collaboration opportunities for the personalized health research community.

Wilhelm Krek (ETH Zurich)
Professor of Biology (Institute for Molecular Health Sciences)
Chair and Co-Founder of NEXUS Personalized Health Technologies
Co-Founder of the Competence Center for Personalized Medicine
Co-Founder of the ETH spin-off ProteoMediX
Niko Beerenwinkel (ETH Zurich)
Associate Professor of Computational Biology
Vice-Chair and Co-Founder of NEXUS Personalized Health Technologies
Co-Director of the Competence Center for Personalized Medicine
Group Leader at the Swiss Institute of Bioinformatics
Daniel Stekhoven
Head Clinical Bioinformatics at NEXUS Personalized Health Technologies
Group Leader at the Swiss Institute of Bioinformatics
Christian Stirnimann
Head Theragnostics Discovery at NEXUS Personalized Health Technologies

Competence Center Personalized Medicine UZH/ETH (CC-PM): a Zurich-based network of researchers and clinicians working in various areas of personalized medicine (University of Zurich, ETH Zurich, and University Hospital Zurich). The Center develops and implements methods for genome-guided diagnosis and therapy based on the genetic disposition of each individual person. CC-PM builds and provides the framework for generating and integrating multidimensional datasets.

Holger Moch (University Hospital Zurich)
Professor of Medicine (Pathology)
Director of the Institute of Pathology and Molecular Pathology
Co-Director of the Competence Center for Personalized Medicine
Niko Beerenwinkel (ETH Zurich)
Associate Professor of Computational Biology
Vice-Chair and Co-Founder of NEXUS Personalized Health Technologies
Co-Director of the Competence Center for Personalized Medicine
Group Leader at the Swiss Institute of Bioinformatics
Silke Schneider
Managing Director of Competence Center Personalized Medicine

Contact

Please contact us for further information at personalizedhealth@nexus.ethz.ch

Disclaimer

Although the organizers take all possible care to ensure the correctness of published information, no warranty can be accepted regarding the correctness, accuracy, reliability and completeness of the content of this information.

The organizers expressly reserve the right to change, to delete or temporarily not to publish the contents wholly or partly at any time and without giving notice.

Liability claims against the organizers or their affiliated institutions, namely ETH Zurich, University of Zurich, University Hospital Zurich, because of tangible or intangible damage arising from accessing, using or not using the published information, through misuse of the connection or as a result of technical breakdowns are excluded.

The organizers have not checked third party web sites, i.e. web sites not located on their servers or in their area of influence, that may be connected to this web site via links, and do not accept any responsibility for the contents or the services offered thereon.

Venue

ETH Zurich main building
HG F 30 (Audi Max)
Rämistrasse 101
CH-8092 Zurich
Switzerland